Health Care & Life Sciences » Pharmaceuticals | Lansen Pharmaceutical Holdings Ltd.

Lansen Pharmaceutical Holdings Ltd.

Lansen Pharmaceutical Holdings Ltd.
Stock Exchange Hong Kong Stock Exchange
EPS
HKD0.08
Market Cap
HKD439.75 M
Shares Outstanding
406.71 M
Public Float
204.68 M

Profile

Address
228 Xinfeng Road
Ningbo Zhejiang 315174
China
Employees -
Website http://www.lansen.com.cn
Updated 07/08/2019
Lansen Pharmaceutical Holdings Ltd. engages in the development, manufacture, and distribution of pharmaceuticals products. It operates through the following segments: Pharmaceuticals, Medicinal Cosmetics Products, and Healthcare Products. The Pharmaceuticals segment develops, produces, and sells specialty pharmaceuticals mainly used in the field of rheumatology and dermatology and other pharmaceuticals.

Financials

View All
Created with Highcharts 5.0.14Lansen Pharmaceutical Holdings Ltd.Net Income. Fiscal year is January-December. All values HKD Thousands.90 68290 682108 410108 41016 05516 05529 77629 776121 793121 7931 2541 254201320142015201620172018025k50k75k100k125k150k
Created with Highcharts 5.0.14Lansen Pharmaceutical Holdings Ltd.Sales/Revenue. Fiscal year is January-December. All values HKD Thousands.737 455737 455905 878905 878723 695723 695736 067736 067697 332697 332445 736445 7362013201420152016201720180250k500k750k1 000k

Zhen Tao Wu
Chairman
Li Chen
CEO, Executive MD & Executive Director